Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Financial Alchemy, LLC was an investment holding entity primarily known for its involvement in a high-profile legal case brought by the U.S. Securities and Exchange Commission (SEC) against the Nutmeg Group and Nanobac Pharmaceuticals. The company was established as a shell entity to hold assets and facilitate transactions for various investment partnerships. While it operated within the financial periphery of the biotechnology sector through its association with Nanobac Pharmaceuticals, it did not engage in independent drug discovery or development. The entity is currently inactive following regulatory actions and legal proceedings related to the mismanagement of fund assets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Financial Alchemy.